Literature DB >> 15306846

Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.

J C Galicia1, H Tai, Y Komatsu, Y Shimada, K Akazawa, H Yoshie.   

Abstract

We have investigated the association of the recently identified IL6R polymorphisms with the serum levels of soluble IL-6 receptor (sIL-6R). sIL-6R is generated by shedding of the membrane-bound receptor (IL-6Ralpha) or alternative mRNA splicing. In total, 115 healthy volunteers were genotyped, with 70 of them analyzed for sIL-6R levels. Using the PCR/RFLP methods, two important polymorphic sites were selected for genotyping: the 48892A/C (D358A) in exon 9 and the -183G/A in the promoter region. In exon 9, C allele carriers had higher sIL-6R level (P<0.0001) showing that this sequence variation, which corresponds to the proteolytic cleavage site of IL-6Ralpha, strongly influences the serum sIL-6R levels. In the promoter region, G allele carriers had lower sIL-6R levels (P<0.0082) compared with the A allele carriers. This could be attributed to the linkage disequilibrium (D'=0.54, chi2=51.3, P<0.0001) between the -183G/A and the 48892A/C gene polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306846     DOI: 10.1038/sj.gene.6364120

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  49 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.

Authors:  S Rafiq; T M Frayling; A Murray; A Hurst; K Stevens; M N Weedon; W Henley; L Ferrucci; S Bandinelli; A-M Corsi; J M Guralnik; D Melzer
Journal:  Genes Immun       Date:  2007-08-02       Impact factor: 2.676

Review 3.  Cancer-related fatigue: links with inflammation in cancer patients and survivors.

Authors:  Julienne E Bower
Journal:  Brain Behav Immun       Date:  2007-05-31       Impact factor: 7.217

4.  IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle.

Authors:  Mac B Robinson; Deepak A Deshpande; Jeffery Chou; Wei Cui; Shelly Smith; Carl Langefeld; Annette T Hastie; Eugene R Bleecker; Gregory A Hawkins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

5.  Are IL1B, IL6 and IL6R Gene Variants Associated with Anterior Cruciate Ligament Rupture Susceptibility?

Authors:  Ewelina Lulińska-Kuklik; Ewelina Maculewicz; Waldemar Moska; Krzysztof Ficek; Mariusz Kaczmarczyk; Monika Michałowska-Sawczyn; Kinga Humińska-Lisowska; Maciej Buryta; Jakub Chycki; Pawel Cięszczyk; Piotr Żmijewski; Agata Rzeszutko; Marek Sawczuk; Petr Stastny; Miroslav Petr; Agnieszka Maciejewska-Skrendo
Journal:  J Sports Sci Med       Date:  2019-02-11       Impact factor: 2.988

6.  A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.

Authors:  Patrick C G Haddick; Jessica L Larson; Nisha Rathore; Tushar R Bhangale; Qui T Phung; Karpagam Srinivasan; David V Hansen; Jennie R Lill; Margaret A Pericak-Vance; Jonathan Haines; Lindsay A Farrer; John S Kauwe; Gerard D Schellenberg; Carlos Cruchaga; Alison M Goate; Timothy W Behrens; Ryan J Watts; Robert R Graham; Joshua S Kaminker; Marcel van der Brug
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.

Authors:  T H A Tvedt; R Hovland; G Tsykunova; A B Ahmed; T Gedde-Dahl; Ø Bruserud
Journal:  Clin Exp Immunol       Date:  2018-04-01       Impact factor: 4.330

8.  Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes.

Authors:  S Rafiq; D Melzer; M N Weedon; H Lango; R Saxena; L J Scott; C N A Palmer; A D Morris; M I McCarthy; L Ferrucci; A T Hattersley; E Zeggini; T M Frayling
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

9.  Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma.

Authors:  Fangyi Gu; Abrar A Qureshi; Tianhua Niu; Peter Kraft; Qun Guo; David J Hunter; Jiali Han
Journal:  Melanoma Res       Date:  2008-10       Impact factor: 3.599

10.  IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3.

Authors:  Avanti Desai; Mi-Yeon Jung; Ana Olivera; Alasdair M Gilfillan; Calman Prussin; Arnold S Kirshenbaum; Michael A Beaven; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2016-01-07       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.